Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. April 2024 08:00 ET | Quelle: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
05. April 2024 08:00 ET | Quelle: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024

Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024
03. April 2024 08:00 ET | Quelle: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
05. März 2024 08:00 ET | Quelle: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline
20. Februar 2024 08:00 ET | Quelle: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference
20. Dezember 2023 08:00 ET | Quelle: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Vorherige Seite